Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
Follow-Up Questions
Who is the CEO of Eden Research PLC?
Mr. Sean Smith is the Chief Executive Officer of Eden Research PLC, joining the firm since 2014.
What is the price performance of EDNSF stock?
The current price of EDNSF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Eden Research PLC?
Eden Research PLC belongs to Chemicals industry and the sector is Materials
What is Eden Research PLC market cap?
Eden Research PLC's current market cap is $0
Is Eden Research PLC a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Eden Research PLC, including 2 strong buy, 2 buy, 1 hold, 0 sell, and 2 strong sell
